“…Resistance has been attributed to increased gene dosage of drug transporters or their transcriptional activators (CDR1, CDR2, CZR1, and MRR1 on chr3 (Sanglard et al 1995(Sanglard et al , 1997Chau et al 2004;Coste et al 2004Coste et al , 2006Todd and Selmecki 2020), TAC1 on chr5 (Selmecki et al 2008)), stress response proteins (PBS2 on chr3 (Todd and Selmecki 2020); CGR1 on chr4 (Todd and Selmecki 2020)), and the target enzyme (ERG11 on chr5 (Chau et al 2004;Selmecki et al 2008)). Furthermore, since many genes are affected by an aneuploidy, non-targeted effects may be more common than with singlegene mutations; for example, chr2 aneuploidy selected under caspofungin exposure confers enhanced survival by different mechanisms to hydroxyurea (Yang et al 2019) and tunicamycin (Yang et al 2021b). In some cases, this may provide an enhanced selective effect for aneuploidy to sweep through a population.…”